Skip to main content
Equibles
TMO logo

TMO · Thermo Fisher Scientific Inc.

Track TMO — free

Use TMO with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$613.78 -4.65 (-0.75%) At close · Sep 4
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$228.66B
Shares
369.75M

TMO metrics

96 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$613.78
Market cap
$228.66B

Price action

19 metrics
Price change (1W)
-1.9%
Price change (30D)
+6.6%
Price change (3M)
+28.3%
Price change (6M)
+19.2%
Price change (YTD)
+6.7%
Price change (1Y)
+27.6%
Trailing year
Price change (5Y)
+8.9%
52-week high
$639.45
52-week low
$438.34
Change from 52-week high
-3.3%
Change from 52-week low
+41.1%
Annualized volatility
30.5%
Beta
0.6
RSI (14D)
60.2
Price vs SMA 50
+8.8%
Price vs SMA 200
+15.4%
Avg volume (3M)
2.04M
Relative volume
0.9
Average dollar volume
$1.11B

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
369.75M

Valuation

12 metrics
P / E (TTM)
33.3
Trailing earnings · reciprocal yield 3.0%
PEG ratio
3.6
EV / revenue
5.8×
reciprocal yield 17.1%
EV / EBITDA
—
EV / EBIT
33.2×
reciprocal yield 3.0%
P / sales
4.9×
reciprocal yield 20.3%
P / book
4.3
reciprocal yield 23.0%
FCF yield
3.2%
TTM · current market cap
Buyback yield
2.2%
P / FCF
31.2
reciprocal yield 3.2%
P / operating cash flow
25.4
reciprocal yield 3.9%
Earnings yield
3.0%

Historical valuation

8 metrics
P / E historical average (3Y)
32.0×
reciprocal yield 3.1%
P / E historical average (5Y)
31.1×
reciprocal yield 3.2%
EV / revenue historical average (3Y)
5.3×
reciprocal yield 18.9%
EV / revenue historical average (5Y)
5.5×
reciprocal yield 18.2%
EV / EBIT historical average (3Y)
31.5×
reciprocal yield 3.2%
EV / EBIT historical average (5Y)
29.4×
reciprocal yield 3.4%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.3%
Trailing 12 months
Payout ratio
9.5%
Shareholder yield
2.5%
Dividend / share (TTM)
$1.80
Dividend growth YoY
+9.8%
Dividend growth streak
5
Last ex-dividend
2026-06-15

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-23

Profitability

9 metrics
Gross margin
—
Operating margin
17.6%
Trailing 12 months
Net margin
15.0%
Gross profit (TTM)
$11.33B
Operating profit (TTM)
$8.15B
Net income (TTM)
$6.97B
Trailing 12 months
Diluted EPS (TTM)
$18.59
FCF margin
15.8%
Effective tax rate
7.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$142.47

Growth

11 metrics
Revenue growth YoY
+10.5%
Year over year
Net income growth YoY
+7.4%
Revenue (TTM)
$46.34B
Trailing 12 months
EPS growth YoY
+9.3%
Shares change YoY
-1.9%
Year over year · fewer shares
Revenue CAGR (3Y)
-0.3%
Revenue CAGR (5Y)
+6.7%
EPS CAGR (3Y)
+0.2%
EPS CAGR (5Y)
+2.1%
FCF CAGR (3Y)
-3.1%
FCF CAGR (5Y)
-1.6%

Quality

14 metrics
Return on equity
13.2%
Return on assets
6.2%
Debt / equity
0.9
Current ratio
1.6
EBITDA (TTM)
$6.05B
Free cash flow (TTM)
$7.32B
Quick ratio
1.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
8.0%
Trailing 12 months
Net cash
−$41.59B
Latest balance sheet
Cash & equivalents
$4.06B
Total assets
$113.17B
Total debt
$45.65B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$9.01B
Capital expenditures (TTM)
$1.70B
R&D (TTM)
$1.40B
SG&A (TTM)
$9.03B
Stock compensation (TTM)
$319.00M
R&D / revenue
3.0%
Stock compensation / revenue
0.7%

Ownership (13F)

3 metrics
13F filers
2,625
13F filer change QoQ
+7
Institutional ownership
91.8%

Short interest

3 metrics
Short interest
1.3%
Latest settlement · 2.9 days to cover
Days to cover
2.9d
Short-squeeze score
51 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$61.56M
Insider-sentiment score
30 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 97745 CUSIP 883556102 13F (30d) 1331 filings 1226 filers Visit website Investor relations